Asia Pacific Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucl

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,550	167 Pages	The Insight Partners	January, 2024	TIP18627985

Best Price Guarantee
Price	from $3,550
Length	167 Pages
Publisher	The Insight Partners
Published Date	January, 2024
SKU	TIP18627985

Asia Pacific Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)The Asia Pacific molecular diagnostics market is expected to grow from US$ 3,478.48 million in 2022 to US$ 9,698.11 million by 2030. It is estimated to grow at a CAGR of 13.7% from 2022 to 2030.

Advancements in Molecular Diagnostics Technologies Fuels Asia Pacific Molecular Diagnostics Market

Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.

Asia Pacific Molecular Diagnostics Market Overview

Asia Pacific includes Malaysia, Thailand, India, Singapore, the Philippines, Vietnam, Indonesia, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Rising geriatric population, increasing cancer cases, growing technological advancements, and increasing number of startups, biotechnology, and biopharmaceutical companies are driving the molecular diagnostics market in this region. Moreover, the rise in research activities in the region and the presence of associations or organizations enhancing the quality of care in cancer contribute to the molecular diagnostics market growth.

Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Molecular Diagnostics Market Segmentation

The Asia Pacific molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Asia Pacific molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Asia Pacific molecular diagnostics market share in 2022.

Based on technology, the Asia Pacific molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Asia Pacific molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Asia Pacific molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Asia Pacific molecular diagnostics market share in 2022.

Based on end users, the Asia Pacific molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Asia Pacific molecular diagnostics market share in 2022.

Based on country, the Asia Pacific molecular diagnostics market has been categorized into India, Singapore, Malaysia, Philippines, Thailand, Indonesia, Vietnam, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are some of the leading companies operating in the Asia Pacific molecular diagnostics market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Molecular Diagnostic market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Molecular Diagnostic market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the molecular diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
;

1. Introduction: 1.1 The Insight Partners Research Report Guidance; 1.2 Market Segmentation
2. Executive Summary: 2.1 Key Insights
3. Research Methodology: 3.1 Coverage; 3.2 Secondary Research; 3.3 Primary Research
4. Asia Pacific Molecular Diagnostics Market Landscape: 4.1 Overview; 4.2 PEST Analysis; 4.2.1 Asia Pacific PEST Analysis
5. Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics: 5.1 Key Market Drivers:; 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing; 5.1.2 Surging Prevalence of Associated Diseases; 5.2 Market Restraints; 5.2.1 Limitations Associated with Molecular Testing; 5.3 Market Opportunities; 5.3.1 Advancements in Molecular Diagnostics Technologies; 5.4 Future Trends; 5.4.1 Molecular Diagnostics in Personalized Medicine; 5.5 Impact Analysis:
6. Molecular Diagnostics Market - Asia Pacific Market Analysis: 6.1 Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area: 7.1 Overview; 7.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%); 7.3 Oncology; 7.3.1 Overview; 7.3.2 Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.4 Infectious Disease; 7.4.1 Overview; 7.4.2 Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.5 Genetic Testing; 7.5.1 Overview; 7.5.2 Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.6 Cardiac Diseases; 7.6.1 Overview; 7.6.2 Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.7 Immune System Disorders; 7.7.1 Overview; 7.7.2 Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.8 Others; 7.8.1 Overview; 7.8.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology: 8.1 Overview; 8.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%); 8.3 Polymerase Chain Reaction; 8.3.1 Overview; 8.3.2 PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.2.1 RT-PCR; 8.3.2.1.1 Overview; 8.3.3 RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.3.1 qPCR; 8.3.3.1.1 Overview; 8.3.4 PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.4.1 Multiplex PCR; 8.3.4.1.1 Overview; 8.3.5 Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.5.1 Others; 8.3.5.1.1 Overview; 8.3.6 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT); 8.4.1 Overview; 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.5 DNA Sequencing and Next-Generation Sequencing (NGS); 8.5.1 Overview; 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.6 DNA Microarrays; 8.6.1 Overview; 8.6.2 DNA Microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.7 In-Situ Hybridization (ISH); 8.7.1 Overview; 8.7.2 In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.8 Others; 8.8.1 Overview; 8.8.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services: 9.1 Overview; 9.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%); 9.3 Assays and Kits; 9.3.1 Overview; 9.3.2 Assays and Kits: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 9.4 Instruments; 9.4.1 Overview; 9.4.2 Instruments: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 9.5 Services and Software; 9.5.1 Overview; 9.5.2 Services and Software: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User: 10.1 Overview; 10.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%); 10.3 Hospitals and Clinics; 10.3.1 Overview; 10.3.2 Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 10.4 Diagnostics Laboratories; 10.4.1 Overview; 10.4.2 Diagnostics Laboratories: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 10.5 Research and Academic Institutes; 10.5.1 Overview; 10.5.2 Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 10.6 Others; 10.6.1 Overview; 10.6.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. Asia Pacific Molecular Diagnostics Market - Country Analysis: 11.1 Asia Pacific Molecular Diagnostics Market, Revenue and Forecast to 2030; 11.1.1 Overview; 11.1.1.1 Asia Pacific Molecular Diagnostics Market by Country; 11.1.2 China; 11.1.2.1 Overview; 11.1.3 China: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.4 China: Molecular Diagnostics Market, by Disease Area; 11.1.5 China: Molecular Diagnostics Market, by Technology; 11.1.5.1 China: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.6 China:Molecular Diagnostics Market, by Product and Services; 11.1.7 China: Molecular Diagnostics Market, by End User; 11.1.8 Japan; 11.1.8.1 Overview; 11.1.9 Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.10 Japan: Molecular Diagnostics Market, by Disease Area; 11.1.11 Japan: Molecular Diagnostics Market, by Technology; 11.1.11.1 Japan: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.12 Japan: Molecular Diagnostics Market, by Product and Services; 11.1.13 Japan: Molecular Diagnostics Market, by End User; 11.1.14 India; 11.1.14.1 Overview; 11.1.15 India: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.16 India: Molecular Diagnostics Market, by Disease Area; 11.1.17 India: Molecular Diagnostics Market, by Technology; 11.1.17.1 India: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.18 India: Molecular Diagnostics Market, by Product and Services; 11.1.19 India: Molecular Diagnostics Market, by End User; 11.1.20 Australia; 11.1.20.1 Overview; 11.1.21 Australia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.22 Australia: Molecular Diagnostics Market, by Disease Area; 11.1.23 Australia: Molecular Diagnostics Market, by Technology; 11.1.23.1 Australia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.24 Australia: Molecular Diagnostics Market, by Product and Services; 11.1.25 Australia: Molecular Diagnostics Market, by End User; 11.1.26 South Korea; 11.1.26.1 Overview; 11.1.27 South Korea: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.28 South Korea: Molecular Diagnostics Market, by Disease Area; 11.1.29 South Korea: Molecular Diagnostics Market, by Technology; 11.1.29.1 South Korea: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.30 South Korea: Molecular Diagnostics Market, by Product and Services; 11.1.31 South Korea: Molecular Diagnostics Market, by End User; 11.1.32 Singapore; 11.1.32.1 Overview; 11.1.33 Singapore: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.34 Singapore: Molecular Diagnostics Market, by Disease Area; 11.1.35 Singapore: Molecular Diagnostics Market, by Technology; 11.1.35.1 Singapore: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.36 Singapore: Molecular Diagnostics Market, by Product and Services; 11.1.37 Singapore: Molecular Diagnostics Market, by End User; 11.1.38 Malaysia; 11.1.38.1 Overview; 11.1.39 Malaysia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.40 Malaysia: Molecular Diagnostics Market, by Disease Area; 11.1.41 Malaysia: Molecular Diagnostics Market, by Technology; 11.1.41.1 Malaysia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.42 Malaysia: Molecular Diagnostics Market, by Product and Services; 11.1.43 Malaysia: Molecular Diagnostics Market, by End User; 11.1.44 Philippines; 11.1.44.1 Overview; 11.1.45 Philippines: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.46 Philippines: Molecular Diagnostics Market, by Disease Area; 11.1.47 Philippines: Molecular Diagnostics Market, by Technology; 11.1.47.1 Philippines: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.48 Philippines: Molecular Diagnostics Market, by Product and Services; 11.1.49 Philippines: Molecular Diagnostics Market, by End User; 11.1.50 Thailand; 11.1.50.1 Overview; 11.1.51 Thailand: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.52 Thailand: Molecular Diagnostics Market, by Disease Area; 11.1.53 Thailand: Molecular Diagnostics Market, by Technology; 11.1.53.1 Thailand: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.54 Thailand: Molecular Diagnostics Market, by Product and Services; 11.1.55 Thailand: Molecular Diagnostics Market, by End User; 11.1.56 Indonesia; 11.1.56.1 Overview; 11.1.57 Indonesia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.58 Indonesia: Molecular Diagnostics Market, by Disease Area; 11.1.59 Indonesia: Molecular Diagnostics Market, by Technology; 11.1.59.1 Indonesia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.60 Indonesia: Molecular Diagnostics Market, by Product and Services; 11.1.61 Indonesia: Molecular Diagnostics Market, by End User; 11.1.62 Vietnam; 11.1.62.1 Overview; 11.1.63 Vietnam: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.64 Vietnam: Molecular Diagnostics Market, by Disease Area; 11.1.65 Vietnam: Molecular Diagnostics Market, by Technology; 11.1.65.1 Vietnam: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.66 Vietnam: Molecular Diagnostics Market, by Product and Services; 11.1.67 Vietnam: Molecular Diagnostics Market, by End User; 11.1.68 Rest of Asia Pacific; 11.1.68.1 Overview; 11.1.69 Rest of Asia Pacific: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.70 Rest of Asia Pacific: Molecular Diagnostics Market, by Disease Area; 11.1.71 Rest of Asia Pacific: Molecular Diagnostics Market, by Technology; 11.1.71.1 Rest of Asia Pacific: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.72 Rest of Asia Pacific: Molecular Diagnostics Market, by Product and Services; 11.1.73 Rest of Asia Pacific: Molecular Diagnostics Market, by End User
12. Asia Pacific Molecular Diagnostics Market Industry Landscape: 12.1 Overview; 12.2 Growth Strategies Done by the Companies in the Market (%); 12.3 Organic Developments; 12.3.1 Overview; 12.4 Inorganic Developments; 12.4.1 Overview
13. Asia Pacific Molecular Diagnostics Market, Key Company Profiles: 13.1 Abbott Laboratories; 13.1.1 Key Facts; 13.1.2 Business Description; 13.1.3 Products and Services; 13.1.4 Financial Overview; 13.1.5 SWOT Analysis; 13.1.6 Key Developments; 13.2 Agilent Technologies Inc; 13.2.1 Key Facts; 13.2.2 Business Description; 13.2.3 Products and Services; 13.2.4 Financial Overview; 13.2.5 SWOT Analysis; 13.2.6 Key Developments; 13.3 Thermo Fisher Scientific Inc; 13.3.1 Key Facts; 13.3.2 Business Description; 13.3.3 Products and Services; 13.3.4 Financial Overview; 13.3.5 SWOT Analysis; 13.3.6 Key Developments; 13.4 F. Hoffmann-La Roche Ltd; 13.4.1 Key Facts; 13.4.2 Business Description; 13.4.3 Products and Services; 13.4.4 Financial Overview; 13.4.5 SWOT Analysis; 13.4.6 Key Developments; 13.5 Qiagen NV; 13.5.1 Key Facts; 13.5.2 Business Description; 13.5.3 Products and Services; 13.5.4 Financial Overview; 13.5.5 SWOT Analysis; 13.5.6 Key Developments; 13.6 bioMerieux SA; 13.6.1 Key Facts; 13.6.2 Business Description; 13.6.3 Products and Services; 13.6.4 Financial Overview; 13.6.5 SWOT Analysis; 13.6.6 Key Developments; 13.7 Illumina Inc; 13.7.1 Key Facts; 13.7.2 Business Description; 13.7.3 Products and Services; 13.7.4 Financial Overview; 13.7.5 SWOT Analysis; 13.7.6 Key Developments; 13.8 Danaher; 13.8.1 Key Facts; 13.8.2 Business Description; 13.8.3 Products and Services; 13.8.4 Financial Overview; 13.8.5 SWOT Analysis; 13.8.6 Key Developments; 13.9 Siemens Healthineers AG; 13.9.1 Key Facts; 13.9.2 Business Description; 13.9.3 Products and Services; 13.9.4 Financial Overview; 13.9.5 SWOT Analysis; 13.9.6 Key Developments; 13.10 Novartis AG; 13.10.1 Key Facts; 13.10.2 Business Description; 13.10.3 Products and Services; 13.10.4 Financial Overview; 13.10.5 SWOT Analysis; 13.10.6 Key Developments; 13.11 TBG Diagnostics Limited; 13.11.1 Key Facts; 13.11.2 Business Description; 13.11.3 Products and Services; 13.11.4 Financial Overview; 13.11.5 SWOT Analysis; 13.11.6 Key Developments
14. Appendix: 14.1 About Us; 14.2 Glossary of Terms
LIST OF TABLES: Table 1. Asia Pacific Molecular Diagnostics Market Segmentation; Table 2. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 3. China:Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 4. China: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 5. China: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 6. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 7. Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Area; Table 8. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Technology; Table 9. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 10. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Product and Services; Table 11. Japan: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 12. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 13. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 14. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 15. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 16. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 17. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 18. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 19. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 20. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 21. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 22. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 23. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 24. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 25. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 26. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 27. Singapore: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 28. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 29. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 30. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 31. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User; Table 32. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 33. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 34. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 35. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 36. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 37. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 38. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 39. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 40. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 41. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 42. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 43. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 44. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 45. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 46. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 47. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 48. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 49. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 50. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 51. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 52. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 53. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 54. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 55. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 56. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 57. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 58. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 59. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 60. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 61. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 62. Organic Developments Done By Companies; Table 63. Inorganic Developments Done By Companies; Table 64. Glossary of Terms, Molecular Diagnostics Market
LIST OF FIGURES: Figure 1. Asia Pacific - PEST Analysis; Figure 2. Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics; Figure 3. Impact Analysis of Drivers and Restraints; Figure 4. Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030; Figure 5. Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%); Figure 6. Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 7. Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 8. Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 9. Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 10. Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 11. Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 12. Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%); Figure 13. PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 14. RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 15. qPCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 16. Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 17. Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 20. DNA microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 21. In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 22. Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 23. Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%); Figure 24. Assays and Kits: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 25. Instruments: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 26. Services and Software: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 27. Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%); Figure 28. Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 29. Ambulatory Surgical Centers: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 30. Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 31. Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 32. Asia Pacific Molecular Diagnostics Market, By Country, 2022 (US$ Mn); Figure 33. Asia Pacific Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%); Figure 34. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 35. Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); Figure 36. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 37. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 38. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 39. Singapore: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 40. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 41. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 42. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 43. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 44. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 45. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 46. Growth Strategies Done by the Companies in the Market (%)